Draft Mission Statement

The mission statement of the Science & Evidence Council is currently under review.

Organizing Committee

Abramson, John_ScienceAndEvidenceJohn Abramson, MD, MSc
Lecturer in Health Care Policy
Harvard Medical School
Why did you join this council? 

I joined the council because of the urgency of broadening the understanding that most of what healthcare professionals, policy makers, and the public believe to be true about medical science is based on unverified, non-transparent, commercially-generated reports of commercially sponsored clinical trials. Under these conditions, the right care is often impossible to determine.

 

Ahmed M. Bayoumi, MD, MSc, FRCPC
Fondation Baxter & Alma Ricard Chair in Inner City Health,
Centre for Research on Inner City Health
Li Ka Shing Knowledge Institute, St. Michael’s Hospital
University of Toronto
Why did you join this council? 

I joined the alliance because I strongly believe that everyone has a right to health and that an efficient, safe, and effective health care system is a powerful means to accomplish that objective. Working with other people at a system level is essential to bring about such change.

 

 

benjamin djulbegovic photoBenjamin Djubegovic, MD, PhD

Benjamin Djulbegovic is a Distinguished Professor and Professor of Medicine and Oncology at the University of South Florida and H Lee Moffitt Cancer Center & Research Institute. He also serves as the Associate Dean for Evidence-based Medicine & Comparative Effectiveness Research at the University of South Florida.

Dr. Djulbegovic’s main academic and research interest lies in attempts to optimize clinical research and practice of medicine by understanding both nature of medical evidence and decision-making. The role of uncertainty and rationality in science and clinical medicine has been one of the common themes across his work, particularly evident on his analysis of equipoise and role of regret. As of May of 2016, he has published close to 300 papers in peer-review journals, 170 abstracts, and two books.

 

Lown-vertical-red-bgPeter Doshi

Bio coming soon 

 

 

 

 

 

 

 

Lown-vertical-red-bgCurt Furberg

Bio coming soon 

 

 

 

 

 

 

 

gordon guyatt photoGordan Guyatt MD, FRCP(C), OC

Dr. Guyatt’s areas of interest include: the dissemination of concepts of evidence-based medicine to health workers and health-care consumers; the methodology of clinical practice guidelines and medical decision-making; systematic review methodology; and ascertaining patients’ values and preferences. Dr. Guyatt has been a leading exponent of evidence-based approaches to clinical practice, having coined the term “evidence-based medicine” in 1990.

 

 

 

 

 

Hoffman, Jerome_Science and EvidenceJerome Hoffman, MD

Bio coming soon 

 

 

 

 

 

 

Lown-vertical-red-bgJohn Ioannidis

Bio coming soon 

 

 

 

 

 

 

 

casey quinlan photoCasey Quinlan
Mighty Casey Media
Journalist, author, open data/open science activist

Casey Quinlan covered her share of medical stories as a TV news field producer, then got a breast cancer diagnosis five days before Christmas in 2007. She used her research, communication, and comedy skills to navigate treatment, and wrote “Cancer for Christmas: Making the Most of a Daunting Gift” about managing medical care, and the importance of health literate self-advocacy. In addition to her ongoing work as a journalist, she’s also part of the My Ideal Patient Experience consulting group, and is a popular speaker on healthcare system transformation from the ground up.In 2014, she participated in the development of the Patient and Family Engagement Roadmap, was identified as a patient engagement expert by the WHO, and returned to MedX as a panel presenter on the PFE Roadmap project. In 2015, Casey was invited to present at HIMSS Patient Engagement Summit, HIMSS Privacy & Security Forum, and DellWorld 2015 as a patient voice on topics from trust in the clinical relationship to data security issues in medical record interoperability. Her speaking calendar for 2016 includes Academy Health’s National Health Policy Conference, the 7th Patient Engagement, Education and Adherence Summit, the ePharma Summit, the Genetic Alliance’s Building Trustworthiness in PCORnet meeting, and Health Datapalooza.

Prasad, Vinay_Science and EvidenceVinay Prasad, MD, MPH
Hematologist-oncologist, Assistant Professor of Medicine
Oregon Health and Sciences University

Vinay K. Prasad MD MPH holds appointments in the Division of Public Health and Preventive Medicine, and as a Senior Scholar in the Center for Health Care Ethics. He is nationally known for his research on oncology drugs, health policy, evidence-based medicine, bias, public health, preventive medicine, and medical reversal. Clinically, Dr. Prasad specializes in the care of lymphoma patients. Dr. Prasad’s work has demonstrated that many medical practices, promoted and advocated for decades, are ultimately shown not to work. These reversals typically occur when we adopt new therapies based on incomplete or inadequate studies. Dr. Prasad has also demonstrated that the high cost of cancer drugs is not explained by rational factors, that media coverage of medical articles preferentially covers lower levels of evidence, that industry sponsored randomized trials have substantial bias, and that many current medical practices have no convincing proof of efficacy (e.g. IVC filters). Dr. Prasad and Dr. Adam Cifu (University of Chicago) are authors of Ending Medical Reversal: Improving Outcomes, Saving Lives (Johns Hopkins University Press, 2015). Dr. Prasad’s work was covered extensively in a profile in the Portland Tribune.